Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HSK-21542 by Sichuan Haisco Pharmaceutical for Post-Operative Pain: Likelihood of Approval
HSK-21542 is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase III for Post-Operative Pain. According to GlobalData,...
Data Insights
HSK-21542 by Sichuan Haisco Pharmaceutical for Unspecified Toxic Disorders: Likelihood of Approval
HSK-21542 is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase II for Unspecified Toxic Disorders. According to...